Dataset for: Fusion of fibroblast growth factor 21 to a thermally responsive biopolymer forms an injectable depot with sustained anti-diabetic action

Published: 8 March 2018| Version 2 | DOI: 10.17632/y3ybyx47sx.2
Contributor:
Caslin Gilroy

Description

All raw data associated with the article, separated into individual tabs.

Files

Categories

Biomedical Engineering, Drug Delivery, Type 2 Diabetes

Licence